Fairness opinions › Bankers
Craig-Hallum: healthcare fairness opinions
2 opinions in healthcare transactions, 2022-2023 — 2 to the target board. Each links to the filing and the full summary of analyses.
Opinions
2
2022-2023
Typical DCF discount rate
16.0%–20.0%
median of low / high · n=1
Terminal method
exit multiple 1
Median disclosed fee
$1.3M
n=1
Deals
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate |
|---|---|---|---|---|---|---|---|
| 2023-01-31 | Chembio Diagnostics | Biosynex SA | Diagnostics / Life Sciences | $17.2M | — | 0.55x | 16.0%–20.0% |
| 2022-05-23 | CynergisTek | Clearwater Compliance | Outsourced Services | $17.7M | — | 0.92x | 20.0%–24.0% |
Segments: Diagnostics / Life Sciences (1) · Outsourced Services (1)
3,000+ healthcare deal-level valuation multiples
The Valuation database includes financial details for more than 3,000 healthcare M&A transactions, private and public, with deal-level multiples, categorized by segment, type, and year.